Skip to main content
. 2000 Mar 20;191(6):977–984. doi: 10.1084/jem.191.6.977

Figure 7.

Figure 7

Binding of Stat5 to the bcl-x promoter in blast crisis and chronic phase CML cells. CD34+ cells were isolated from the peripheral blood of patients with CML in blast crisis and chronic phase, and treated for 3 h with CGP 57148 or tyrphostin AG 555. An EMSA was performed using a radiolabeled bcl-x probe. Nuclear extracts from untreated cells (C) were preincubated with antibodies specific for Stat5 (+anti-ST5), and with an excess of an unlabeled bcl-x probe as a specific competitor (+SP) or with an irrelevant nonspecific probe (+non-SP).